Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.7200 (1.97%) ($20.3100 - $21.3900) on Fri. Dec. 28, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.08% (three month average) | RSI | 30 | Latest Price | $20.7200(1.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -17.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.54% in a week (0% probabilities). VXX(-13%) VIXM(-10%) GDXJ(-5%) TLT(-4%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.54% (StdDev 5.08%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
1 - 5 Day Possible Target | $-5.82(-128.09%) | Resistance Level | $26.21 | 5 Day Moving Average | $19.87(4.28%) | 10 Day Moving Average | $22.78(-9.04%) | 20 Day Moving Average | $26.21(-20.95%) | To recent high | -34.9% | To recent low | 13.9% | Market Cap | $1.287b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |